| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 |
| filingDate |
2003-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c7283f032fa54a699227d8282a98cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_797b810b6146fca1e5ff932b59e0bc7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0728fadac7202408a2bc3073ad7cd82f |
| publicationDate |
2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2309294-T3 |
| titleOfInvention |
PHARMACEUTICAL DOSAGE FORMS OF CONTROLLED RELEASE OF AN INHIBITOR OF THE PROTEIN OF TRANSFER OF ESTER DE COLESTERILO. |
| abstract |
A controlled release dosage form comprising: (a) an enhanced solubility form of a cholesteryl ester transfer protein (CETPI) inhibitor, the CETPI being selected from the group consisting of the compounds of Formula XVI: (See formula) and its pharmaceutically acceptable forms, in which: nXVI is an integer selected from 1 to 4; XXVI is oxy; RXVI-1 is selected from the group consisting of haloalkyl, haloalkenyl, haloalkoxymethyl and haloalkenyloxymethyl, with the proviso that RXVI-1 has a score in the Cahn-Ingold-Prelog stereochemical system greater than RXVI-2 and (CHRXVI-3) nN (AXVI) QXVI, in which AXVI is Formula XVI- (II) and Q is Formula XVI- (III); (See formulas) RXVI - 16 is selected from ... |
| priorityDate |
2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |